Abstract
The sequencing of the human and mouse genomes and the identification of expressed genes in a variety of normal and diseased tissues are bringing a new era to biomedical research. In this new era Bioinformatics will play an increasingly important role in predicting gene function. This will be based on sequence homology, identification of functional domains and phylogeny. These analyses may to some extent be at the expense of many of the experimental approaches that have be used by biomedical scientists for decades. Analysis of the extensive databases from normal and diseased tissues will enable the prediction of potential disease candidate genes or genes which are putatively involved in a specific biological processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bacchus C., Sterz H., Buselmaier W., Sahai S. and Winking H. Genesis and systematization of cardiovascular anomalies and analysis of skeletal malformations in mutine trisomy 16 and 19. Two animal models for human trisomies. Hum Genet. 1987; 77:12–22
Bassuk A.G. and Leiden J.M. The role of Ets transcription factors in the development and function of the Immune system. Adv.Immunol. 1997; 64:65–104
Becker L., Mito T., Takashima S. and Onodera K. Growth and development of the brain in Down Syndrome. Prog.Clin.Biol.Res. 1991; 373:133–152.
Blendy J.A., Kaestner K.H., Schmid W., Gass P. and Schutz G. Targeting of the CREB gene leads to upregulation of a novel CREB mRNA isoform. EMBO J. 1996; 15:1098–1106.
Bossard, M.J., Tomaszek, T.A., Thompson, S.K., Amegadzie, B.Y., Hanning, C.R., Jones, C., Kurdyla, J.T., McNulty, D.E., Drake, F.H., Gowen, M. and Levy, M.A. Proteolytic activity of human osteoclast cathepsin K. J.Biol.Chem. 1996;. 217: 12517–12524.
Bradley A., Evans M., Kaufman M.H. and Robertson E. Formation of germline chimeras from embryo derived teratocarcinoma cell lines. Nature. 1984; 309:255–256.
Davisson M.T., Schmidt C., Reeves R.H., Irving N.G., Akeson E.C., Harris B.S. and Bronson R.T. Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 1993; 384:117–133
de Gouyon B, Melanitou E, Richard MF, Requarth M, Hahn IH, Guenet JL, Demenais F, Julier C., Lathrop GM, Boitard C. and Avner P. Genetic analysis of diabetes and insulitis in an interspecific cross of the nonobese diabetic mouse with Mus spretus. Proc Natl Acad Sci USA. 1993; 90:1877–1881.
de La Coste A, Mignon A, Fabre M, Gilbert E, Porteu A, Van Dyke T, Kahn A, Perret C. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. Cancer Res. 1999; 59:5017–5022.
Demas G.E., Nelson R.J., Krueger B.K. and Yarowsky P.J. Impaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice. Behav Brain Res. 1998; 90:199–201
Demas G.E., Nelson R.J., Krueger B.K. and Yarowsky P.J. Spatial memory deficits in segmentai trisomic Ts65Dn mice. Behav Brain Res. 1996; 82:85–92
Dierssen M., Vallina I.F., Baamonde C., Garcia-Calatayud S., Lumbreras M.A. and Florez J. Alterations of central noradrenergic transmission in Ts65Dn mouse, a model for Down syndrome. Brain Res. 1997; 749:238–244
Doetschman T., Gregg R.G., Maelda N., Hooper M.L., Melton O.W., Thompson S. and Smithers O. Targeted correction of mutant HPRT gene in mouse embryonic stem cells. Nature. 1987; 330:576–578.
Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr C.A., Blutel J.S and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356:215–221.
Drake, F.H., Dodds, R.A., James, I.E., Connor, J.R., Debouck, C., Richardson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G. and Gowen, M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J. Biol. Chem. 1996; 217: 12511–12516.
Edelson, J.G., Obad, S., Geiger, R., et al. Pycnodysostosis; orthopedic aspects with a description of 14 new cases. Clin.Orthop.Rel.Res. 1992; 280:263–276
Elmore, S.M. and Virginia, R. (1967) Pycnodysostosis: A review., J. Bone Joint Surg. 49:153–162
Encinas J.A., Wicker L.S., Peterson L.B., Mukasa A., Teuscher C., Sobel R., Weiner H.L., Scidman C.E., Scidman J.G. and Kuchroo V.K. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing IL2. Nat Genet. 1999; 21:158–160.
Epstein C.J.; Hofmeister B.G.; Yee D.; Smith S.A.; Philip R.; Cox D.R.; Epstein L.B. Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16. J Exp Med. 1985; 162:695–712.
Escorihuela R.M., Vallina I.F., Martinez-Cue C., Baamonde C., Dierssen M., Tobena A., Florez J., and Fernandez-Teruel A. Impaired short-and long-term memory in Ts65Dn mice, a model for Down’s syndrome. Neurosci Lett. 1998; 247:171–174
Evans M.J. and Kaufman M.H. Establishment in culture of pluripotent cells from mouse embryos. Nature. 1981; 292:154–156.
Fassati A, Wells DJ, Sgro Serpente PA, Walsh FS, Brown SC., Strong PN, Dickson G. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells. J Clin Invest. 1997; 100:620–628.
Favor J, Neuhauser-Klaus A and Ehling UH. The induction of forward and reverse specific-locus mutations and dominant cataract mutations in spermatogonia of treated strain DBA/2 mice by ethylnitrosourea. Mutat Res. 1991; 249:293–300.
Folger K.R., Wong E.A. Wahl G. and Capecchi M.R. Patterns of integration of DNA microinjeeted into cultured mammalian cells: evidence of homologous recombination between injected plasmid DNA molecules. Mol.Cell.Biol. 1982; 2:1372–1387.
Gahtan E., Auerbach J.M., Groner Y. and Segal M. Reversible impairment of long-term potentiation in transgenic Cu/Zn-SOD mice. Eur J Neurosci. 1998; 10:538–544
Garnero, P., Drake, F.H., Foged, N.T., Delmas, P.D., and Delaissé, J. The collagenolytic efficiency of osteoclast cathepsin K in unique amongst vertebrate proteinases. J. Bone Min. Res. 1997; 12: 155.
Gelb, B.D., Shi, G.P., Chapman, H.A., and Desnick, R.J. Pycnodysostosis, a lysosomal disease caused by Cathepsin K deficiency. Science. 1996; 273:1236–1238.
Geng Y, Whoriskey W, Park MY, Bronson RT, Medema RH, Li T, Weinberg RA, Sicinski P. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell. 1999; 97:767–777.
Gowen, M., Lazner, F., Dodds, R., Feild, J, et al. Cathepsin K knockout mice develop osteoporosis due to a deficit in matrix degradation but not demineralisation. J. Bone Min. Res. 1999; 14:1654–1663.
Gu H, Marth JD, Orban PC., Mossmann H, Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 1994; 265:103–106.
Hernandez D, Mee PJ, Martin JE, Tybulewicz VL, Fisher EM. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. Hum Mol Genet. 1999; 8:923–933.
Hertzog PJ, Hwang SY, Holland KA, Tymms MJ, Iannello R, Kola I. A gene on human chromosome 21 located in the region 21q22.2 to 21q22.3 encodes a factor necessary for signal transduction and antiviral response to type I interferons. J Biol Chem. 1994; 269:14088–14093.
Hou, W.S., Bromme, D., Zhao, Y., Mehler, E., Dushey, C., Weinstein, H., Miranda, C.S., Fraga, C., Greig, F., Carey, J., Rimoin, D.L., Desnick, R.J. and Gelb, B.D. Characterisation of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J. Clin. Invest. 1999; 103:731–738.
Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., Chan P.H., Scott R.W. and Epstein C.J. Superoxide-mediated cytotoxicity in Superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys 1997; 344:424–432
Hustad CM, Perry WL, Siracusa LD, Rasberry C, Cobb L, Cattanach BM, Kovatch R, Copeland NG, Jenkins NA. Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics. 1995; 140:255–265.
Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I and Kola I. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci USA. 1995; 92:11284–11288.
Ichida M, Hakamata Y, Hayakawa M, Ueno E, Ikeda U, Shimada K, Hamamoto T, Kagawa Y, Endo H. (2000) Differential Regulation of Exonic Regulatory Elements for Muscle-specific Alternative Splicing during Myogenesis and Cardiogenesis. J Biol Chem. 2000; 275; 15992–16001.
Johnson, M.R., Polymeropoulos, M.H., Vos, H.L., Ortiz de Luna, R.I. and Francomano, C.A. A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res. 1996; 6: 1050–1055.
Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Mouse ENU mutagenesis. Hum Mol Genet. 1999; 8:1955–1963.
King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP, Steeves TD, Vitaterna MH, Kornhauser JM, Lowrey PL, Turek FW, Takahashi JS. Positional cloning of the mouse circadian clock gene. Cell. 1997; 89:641–653.
Kola I, Hertzog PJ. Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. Hum Mol Genet. 1997; 6:1713–1727.
Kola, I. and Wilton, L. Preimplantation Embryo Biopsy: Detection of trisomy in a single cell biopsied from a four-cell mouse embryo. Mol. Reprod. Dev. 1991; 29:16–21.
Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A. The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA. 1993; 90:7588–7592.
Kola I. Simple minded mice from’ in vivo’ libraries. Nat Genet. 1997; 16:8–9.
Lamb B.T., Sisodia S.S., Lawler A.M., Slunt H.H., Kitt C.A., Kearns W.G., Pearson P.L., Price D.L. and Gearhart J.D. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice. Nat Genet. 1993; 5:22–30.
Lazner, F., Gowen, M. and Kola, I. An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling. Mol Med Today. 1999a; 5:413–414
Lazner, F., Gowen, M., Pavasovic, D. and Kola, I.. Osteopetrosis and osteoporosis: two sides of the same coin. Hum. Mol. Genet. 1999b; 8:1839–1846
Lee EY, Chang CY, Hu N, Wang YC., Lai CC., Herrup K, Lee WH, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992; 359:288–294.
Levy J. The gastrointestinal tract in Down Syndrome. Prog.Clin.Biol.Res. 1991; 373:245–256.
Li H, Wang J, Wilhelmsson H, Hansson A, Thoren P, Duffy J, Rustin P, Larsson NG. Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy. Proc Natl Acad Sci USA. 2000; 97:3467–3472.
Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C, Fowler KJ, Basu S, Zhan YF, Dunn AR. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84:1737–1746.
Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem. 2000; 275:12712–12718.
Long L, Richsmeier JT, Lubensky A, Yo M, Abrams M, Patwardhan A, Reiss A, Reeves RH. Abstract 47. 7th International Workshop on Human Chromosome 21, Berlin, Germany. September 1997.
Lyons PA, Armitage N, Argentina F, Denny P, Hill NJ, Lord CJ, Wilusz MB, Peterson LB, Wicker LS, Todd JA. Congenic mapping of the type 1 diabetes locus, idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 2000; 10:446–453.
Lyons P.A. and Wicker L.S. Localising polygenes in the NOD mouse model of type I diabetes. In Genetics in autoimmunity A. Theofilopoulos, ed, p 208–225 Karger, Basel Switzerland. 1999.
Martin G. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma cells. Proc. Natl. Acad. Sci USA. 1981; 78:7634–7638.
McDonald JD, Bode VC., Dove WF, Shedlovsky A. Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA. 1990; 87:1965–1967.
Miyabara S., Gropp A. and Winking H. Trisomy 16 in the mouse fetus associated with generalized edema and cardiovascular and urinary tract anomalies. Teratology. 1982; 25:369–380
Monroe RJ, Scidl KJ, Gaertner F, Han S, Chen F, Sekiguchi J, Wang J, Ferrini R, Davidson L, Kelsoe G, Alt FW. RAG2.GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity. 1999; 11:201–212.
Moon AM, Boulet AM, Capecchi MR. (2000) Normal limb development in conditional mutants of Fgf4. Development. 2000; 127:989–996.
Moore K.J. Insight into the microphthalmic gene. Trends Genet. 1995; 11:442
Muthusamy N, Barton K, Leiden JM. Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature. 1995; 377:639–642.
Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood. 1998; 91:3134–3143.
Quon D., Wang Y., Catalano R., Scardina J.M., Murakami K. and Cordell B. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature. 1991; 352:239–241
Reeves R.H., Robakis N.K., Oster-Granite M.L., Wisniewski H.M., Coyle J.T. and Gearhart J.D. Genetic linkage in the mouse of genes involved in Down Syndrome and Alzheimer’s disease in man. Brain Res. 1987; 388:215–221.
Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T. and Davisson M.T. A mouse model for Down’s syndrome exhibits learning and behaviour deficits. Nat Genet. 1995; 11:177–184
Richards S.J., Edwards P., Waters J., Torres E. and Dunnett S.B. Ultrastuctural neuropathology in murine trisomy 16 hippocampal grafts. Neuro Report. 1993; 4:208–210.
Rinchik EM, Carpenter DA. N-ethyl-N-nitrosourea mutagenesis of a 6-to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics. 1999; 152:373–383.
Robertson E., Bradley A., Kuehn M. and Evans M. Germline transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature. 1986; 323:445–447.
Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome. 1997; 8, 711–713.
Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde A., Rommerskirch W., Moritz J.D., Schu P. and von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice. Proc. Nat.Acad. Sci.USA. 1998; 95, 13453–13458
Sago H., Carlson E.J., Smith D.J., Kilbridge J., Rubin E.M., Mobley W.C., Epstein C.J. and Huang T.T. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA. 1998; 95:6256–6261
Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 1995; 55:3915–3927.
Sauer B, Henderson N. The cyclization of linear DNA in Escherichia coli by site-specific recombination. Gene. 1988; 70:331–341.
Serreze DV, Prochazka M, Reifsnyder PC., Bridgett MM, Leiter EH. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med. 1994; 180:1553–1558.
Siarey R.J., Stoll J., Rapoport S.I. and Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology. 1997; 36:1549–1554
Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 1995; 269:234–238.
Smith D.J., Zhu Y., Zhang J., Cheng J.F. and Rubin E.M. Construction of a panel of transgenic mice containing a contiguous 2-Mb set of YAC/P1 clones from human chromosome 21q22.2. Genomics. 1995; 27:425–434
Smith D.J., Stevens M.E., Sudanagunta S.P., Bronson R.T., Makhinson M., Watabe A.M., O’Dell T.J., Fung J., Weier H.U., Cheng J.F. and Rubin E.M. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet. 1997; 16:28–36
Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, Maher DW, Cebon J, Sinickas V, Dunn AR. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA. 1994; 91:5592–5596.
Sumarsono S.H., Wilson T.J., Tymms M.J., Venter D.J., Corrick C.M., Kola R., Lahoud M.H., Papas T.S., Seth A. and Kola I. Down’s syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature. 1996; 379:534–537
Thomas K.R. and Capecchi M.R. Site directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 1987; 51:503–512.
Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ and Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995; 269:230–234.
Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JR, Hearne CM, Knight AM, Love JM, McAleer MA, Prins JB, Rodrigues N, Lathrop M, Pressey A, DeLarato NH, Peterson LB and Wicker LS. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 1991; 351:542–547
Tomizuka K., Yoshida H., Uejima H., Kugoh H., Sato K., Ohguma A., Hayasaka M., Hanaoka K., Oshimura M. and Ishida I. Functional expression and germline transmission of a human chromosome fragment in chimaeric mice. Nat Genet. 1997; 16:133–143
Wang J, Wilhelmsson H, Graff C, Li H, Oldfors A, Rustin P, Bruning JC, Kahn CR, Clayton DA, Barsh GS, Thoren P, Larsson NG. Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression. Nat Genet. 1999; 21:133–137.
Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992; 176:1645–1656.
Wolvetang E.J., Hatzistavrou T., Lazner D., Wilson T.J., Seth A., Hertzog P. and Kola I. Ets-2 overexpression prediposes cells to apoptosis via a pathway involving p53 and Bcl-2/Bax. 2000. submitted
Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, Maki RA, Werb Z, Oshima RG. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 1998; 12:1315–1326.
Zheng B, Mills AA, Bradley A. A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res. 1999; 27:2354–2360.
Zhumabekov T, Corbella P, Tolaini M, Kioussis D. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J Immunol Methods. 1995; 185:133–140.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wilson, T.J., Lazner, F., Kola, I., Hertzog, P.J. (2000). The Mouse and the Genomic Era. In: Clark, M.S. (eds) Comparative Genomics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4657-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4657-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7107-6
Online ISBN: 978-1-4615-4657-3
eBook Packages: Springer Book Archive